乳腺癌骨转移:这一切都是关于邻里
1Department of Medicine, Division of Endocrinology, Indiana University, Indianapolis, IN 46202, USA.
Cell
|September 3, 2013
概括
转移性癌细胞获得器官特异性特征,以殖民遥远的地点. 主要瘤流体信号会影响乳腺癌细胞.
科学领域:
- 在瘤学瘤学.
- 癌症转移 癌症转移
- 细胞生物学 细胞生物学
背景情况:
- 转移性癌细胞需要器官特异性适应才能成功殖民.
- 瘤微环境,包括初级肌层,在癌症进展中起着至关重要的作用.
研究的目的:
- 调查原发性瘤流体如何影响乳腺癌细胞中骨转移特异性特征的获得.
主要方法:
- 分析乳腺癌细胞中的基因表达特征.
- 在实验室共培养模型中,主要的瘤流层组件.
- 在体内转移模型.
主要成果:
- 发现,来自原发性瘤流体的信号显著影响与骨转移相关的基因的表达.
- 暴露于初级流体信号的乳腺癌细胞表现出增强殖民骨组织的能力.
结论:
- 主要瘤流层是转移潜力的关键调节者,特别是在乳腺癌中用于骨殖民.
- 向肌肉-肌肉相互作用可以提供新的治疗策略,以防止骨转移.
相关概念视频
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...


